Is renal cell carcinoma the same as kidney cancer?
Renal cell carcinoma (RCC), also known as renal cell cancer or renal cell adenocarcinoma, is the most common type of kidney cancer. About 9 out of 10 kidney cancers are renal cell carcinomas.
Can a person with one kidney drink alcohol?
This means no alcohol. This risk of kidney disease from alcohol is drastically increased with only one kidney. Although you can remain healthy with one kidney, drinking alcohol causes damage beyond your one kidney.
How long can you live after radical nephrectomy?
Untreated patients with metastatic cancer have a median survival of 6 to 12 months and a 5-year survival rate less than 20 percent. Twenty-five percent of the patients will develop metastasis after nephrectomy and the majority (78%) of recurrent RCC occurs within the first five years.
What are the different types of renal cell carcinoma syndromes?
The following four major autosomal dominantly inherited RCC syndromes have been identified. PDQ summaries are available for each of these syndromes: Von Hippel-Lindau Disease (VHL). Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC). Hereditary Papillary Renal Carcinoma (HPRC). Birt-Hogg-Dubé Syndrome (BHD).
What are the most common sites of metastasis in renal cell carcinoma (RCC)?
In some instances RCCs are associated with 2: von Hippel-Lindau syndrome: greater tendency for bilateral RCC as well as a presentation at a younger age; clear cell subtype The most common sites of metastasis are, in order: the lungs, the bones, lymph nodes, the liver, adrenals, and the brain 25.
What is the difference between RCC and non-RCC kidney cancer?
RCC is distinct from kidney cancer that involves the renal pelvis or renal medulla, and it only applies to cancer that forms in the lining of the kidney bed (i.e., in the renal tubules). Non-RCCs of the kidney, including cancer of the renal pelvis or renal medulla, are not addressed in this summary.
What is the life expectancy of someone with metastatic renal cell carcinoma?
At presentation, a third of patients with RCC already have locally advanced or metastatic disease and a third of patients who undergo surgical resection for local disease will have a recurrence. Patients with metastatic RCC (pT4) have a median survival of around 13 months and the 5 year survival rate is under 10% [6].
